期刊文献+

环孢素A纳米粒滴眼液抗大鼠角膜移植术后排斥反应的实验研究 被引量:2

The prevention effect of cyclosporine A nano-particle eye drop on cornea immune rejection in a rat penetrating cornea transplantation model
原文传递
导出
摘要 目的探讨环孢素A纳米粒滴眼液对大鼠同种异体角膜移植术后角膜排斥反应的抑制作用。设计实验研究。研究对象Lewis大鼠50只,F344大鼠25只。方法 Lewis大鼠作为穿透性角膜移植受体分5组各10只,A组为阴性对照组,给予环孢素A纳米粒滴眼液基质点眼,B组为普通环孢素滴眼液组,C、D、E组分别为0.5%、1%、2%环孢素A纳米粒滴眼液组。F344大鼠为供体。术后各组滴用相应的滴眼剂,每日3次。术后14天内每日、14天后每2日拍摄角膜照片,观察至术后28天。术后14天取大鼠角膜组织行组织病理学检查。主要指标角膜植片存活时间、角膜排斥反应指数(RI)、角膜组织病理改变。结果 A、B、C、D、E组角膜植片存活时间分别为8.1±1.37天、12.5±4.72天、12.11±4.46天、13.11±4.65天和13.56±3.88天(F=2.916,P=0.032)。普通环孢素滴眼液组,0.5%、1%、2%环孢素A纳米粒滴眼液组与基质组相比,差异具有统计学意义(P均<0.05)。普通环孢素滴眼液组与0.5%、1%、2%环孢素A纳米粒滴眼液组相比,差异无统计学意义(P均>0.05)。A、B、C、D、E组RI分别为7.3±0.67、5.5±1.35、6.11±1.45、5.22±1.48和4.77±1.20(,F=5.782,P=0.001)。普通环孢素滴眼液组、0.5%、1%、2%环孢素A纳米粒滴眼液组与基质组相比,RI有统计学意义(P均<0.05。普通环孢素滴眼液组与0.5%、1%、2%环孢素A纳米粒滴眼液组比较,差异无统计学意义(P均>0.05)。2%环孢素A纳米粒滴眼液组与0.5%环孢素A纳米粒滴眼液组比较差异具有统计学意义(P=0.03)。结论环孢素A纳米粒滴眼液与普通环孢素滴眼液具有相似的抑制角膜移植术后排斥反应的作用,2%环孢素A纳米粒滴眼液组效果优于0.5%浓度组。 To investigate the prevention effect of cyclosporine A nanoparticle eye drop on cornea immune rejection in a rat experimental model. Design Experimental study. Participants Fifty Lewis rats and twentyfive F344 rats. Method Fifty Lewis rats were divided into 5 groups (group A to group E), all of which were received penetrating cornea transplantation in the right eyes. The provider were F344 rats. Group A received vehicle eye drop, group B received ordinary cyclosporine eye drop, group C to E received 0.5%, 1% and 2% cyclosporine A nanoparticle eye drop respectively. All the receptor eyes received the eye drops 4 times a day. Cornea were observed with slit lamp and photographs were taken everyday within 14 days after cornea transplantation, and then ob- served every other day until 28 days. The mean survival time and rejection index (RI) were calculated. The corneas were studied pathologically at day 14th. Main Outcome Measures Cornea survival time, rejection index, pathologically observation of cornea. Results The mean survival time in group A, B, C, D, E were 8.1±1.37 days, 12.5±4.72 days, 12.11±4.46 days, 13.11±4.65 days and 13.56±3.88 days respectively(F=2.916, P=0.032). The survival time in any of group B, C, D, E is longer compared with group A (all P〈0.05). RI of group A to E was 7.3±0.67, 5.5±1.35, 6.11±1.45, 5.22±1.48 and 4.77±1.20, respectively (F=5.782, P=0.001). RI in group B, C, D, E is lower compared with group A (all P〈0.05). No significant difference was found between any of group C, D, E and ordinary cyclosporine eye drop (P=0.297, 0.634, 0.219). But significant difference was found between 2% cyclosporine A nanoparticle group and 0.5% group (P=0.03). Conclusion Cyclosporine A nanoparticle eye drop can effectively prevent cornea rejection after penetrating cornea trans plantation. Its effect is similar to ordinary cyclosporine eye drop. The effect of 2% eyclosporine A nanoparticle eye drop was better than 0.5% cyclosporine A nanoparticle eye drop. (Ophthalmol CHN, 2012, 21: 55-59)
出处 《眼科》 CAS 2012年第1期55-59,共5页 Ophthalmology in China
基金 北京市科技计划课题资助项目(Z09050700620908)
关键词 穿透性角膜移植 免疫排斥 环孢素A 纳米粒滴眼液 penetrating corneal transplantation immune rejection Cyclosporine A nanoparticle eye drop
  • 相关文献

参考文献13

  • 1Shimazaki J,Den S,Omoto M,et al.Prospective randomized studyof the efficacy of systemic cyclosporine in high-risk cornealtrans-plantation.Am J Ophthalmol,2011,152:33-39.
  • 2Shi W,Chen M,Xie L.Prolongation of corneal allograft survivalby CTLA4-FasL in a murine model.Graefes Arch Clin Exp Oph-thalmol,2007,245:1691-1697.
  • 3Yan W,Mingjun L,Hongxia G.Polymeric micelle composed ofPLA and chitosan as a drug carrier.J Polym Res,2009,16:11-18.
  • 4Unal M,Yücel I.Evaluation of topical ciclosporin 0.05%for pre-vention of rejection in high-risk corneal grafts.Br J Ophthalmol,2008,92:1411-1414.
  • 5白浪,陆晓和,于健,钟彦彦,武海军,熊柯.TLRs在大鼠穿透角膜移植术后排斥反应中的作用[J].眼科研究,2010,28(6):491-495. 被引量:2
  • 6翟长斌,张文华,邹留河,潘志强,李纳,武宇影,吕岚,张士元,马大龙.白细胞介素-1受体拮抗剂防治角膜移植免疫排斥反应的实验研究[J].中华眼科杂志,2001,37(4):270-272. 被引量:8
  • 7Sedlakova K,Filipec M.Effect of suturing technique on cornealxenograft survival.Cornea,2007,26:1111-1114.
  • 8张文华,潘志强,翟长斌,武宇影,刘海霞,李辽青,李纳,邹留河.国产环孢素A眼液治疗大鼠角膜移植术后免疫排斥反应的研究[J].中华眼科杂志,2001,37(2):140-143. 被引量:13
  • 9Holland EJ,Chan CC,Wetzig RP,et al.Clinical and immunohistologicstudies of corneal rejection in the rat penetrationg keratoplastymodel.Cornea,1991,10:374-380.
  • 10Utine CA,Stern M,Akpek EK.Clinical review:topical ophthalmicuse of cyclosporin A.Ocular Immuno Inflamm,2010,18:352-361.

二级参考文献37

  • 1吕岚,王荣光,邹留河,董东生.圆锥角膜穿透性角膜移植术前后的角膜地形图分析[J].中华眼科杂志,1998,34(2):156-157. 被引量:2
  • 2吕岚.角膜移植免疫学研究进展[J].国外医学(眼科学分册),1996,20(3):136-140. 被引量:10
  • 3高建鲁,吴欣怡.人角膜上皮细胞Toll样受体介导的炎性细胞因子的表达[J].中华眼科杂志,2006,42(7):628-633. 被引量:15
  • 4白浪,陆晓和,党森涛,周瑾.树突状细胞在大鼠穿透性角膜移植排斥反应中的作用[J].南方医科大学学报,2007,27(1):72-74. 被引量:4
  • 5Williams KA, Muehiberg SM, Lewis RF, et al. How successful is corneal transplantation? A report from the Australian corneal graft register. Eye, 1995,9 : 219-227.
  • 6Gao G, Li Y, Gee S, et al. Down-regulation of vascular endothelial growth factor the anti-angiogenic activity of plasminogen kringle 5. J Biol Chem, 2002,277:9492-9497.
  • 7Cai WB, Ma IF, Li CY, et al. Enhanced anti-angiogenic effect of a deletion mutant of plasminogen Kringle 5 on neovascularization.J Cellul Bioehem, 2005, 96:1254-1261.
  • 8Holland EJ, Chan CC, Wetzig RP, et al. Clinical and immunohistologic studies of corneal rejection in the rat penetrating keratoplasty model. Cornea, 1991, 10: 374-380.
  • 9D'Amato RJ, Loughnan MS, Flyrm E, et al. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci U S A, 1994, 91: 4082-4085.
  • 10Herbort CP, Matsubara M, Nishi M, et al. Penetrating keratoplasty in the rat : a model for the study of immunosuppressive treatment of graft rejection. Jpn J Ophthalmol ,1989,33:212-220.

共引文献19

同被引文献41

引证文献2

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部